The Company uses natural tissues and innovative technologies to produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.


Updates from The Motley Fool

Latest updates on RTI Biologics from Fool.com.


Stock Performance

RTIX vs. S&P 500 | 2 Year Performance
View Interactive RTIX Charts
Sponsored by

Key Data Points

Primary metrics and data points about RTI Biologics.
Current Price: $3.82
Prev Close: $3.76
Open: $3.74
Bid: $3.50
Ask: $4.20
Day's Range: $3.74 - $3.87
52wk Range: $2.81 - $7.48
Volume: 72,024
Avg Vol 172,793
Market Cap: $220.75M
P/E (ttm): 20.89
EPS (ttm): $0.18
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about RTI Biologics.
CAPS Rating 4 out of 5
 
212 Outperform
9 Underperform
CAPS All Stars
 
32 Outperform
2 Underperform

How do you think RTI Biologics will perform against the market?



You pick for RTI Biologics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Brian K. Hutchison, CEO

57% Approve

Based on 11 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for RTI Biologics.

The Company uses natural tissues and innovative technologies to produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT